Dogwood Therapeutics (DWTX) to Release Quarterly Earnings on Wednesday

Dogwood Therapeutics (NASDAQ:DWTX) will likely be issuing its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($1.36) per share for the quarter.

Dogwood Therapeutics Stock Down 8.5 %

NASDAQ:DWTX opened at $5.38 on Monday. The firm has a market capitalization of $7.17 million, a price-to-earnings ratio of -0.82 and a beta of 1.92. Dogwood Therapeutics has a 1-year low of $1.62 and a 1-year high of $29.28. The company’s fifty day simple moving average is $5.83.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.